Filing Flows › Colgate Palmolive (CL) › Q3 2026 › vs Q2 2026
Colgate Palmolive (CL) Q3 2026 vs Q2 2026 (quarter over quarter)
Colgate Palmolive's revenue rose $8.0M (+0.1%) from $5.4B in Q2 2026 to $5.4B in Q3 2026. Gross margin 60.2% against 61.5% (-1.3 pts).
Colgate Palmolive, Q3 2026: revenue $5.4B (+5% year over year), operating margin 20.3%, net earnings $751M, operating cash flow $1.2B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 60.2% | 61.5% | -1.3 pts |
| Operating margin | 20.3% | 19.0% | +1.3 pts |
| Net margin | 14.0% | 12.9% | +1.1 pts |
| Free cash flow margin | 19.3% | 16.2% | +3.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5.4B | $5.4B | $8.0M | +0.1% |
| Gross profit | $3.2B | $3.3B | −$63.0M | -2% |
| Cost of revenue | $2.1B | $2.1B | $71.0M | +3% |
| Operating profit | $1.1B | $1.0B | $72.0M | +7% |
| Operating expenses | $2.1B | $2.3B | −$135M | -6% |
| Pre-tax earnings | $1.0B | $950M | $69.0M | +7% |
| Other expense, net | $69.0M | $66.0M | $3.0M | +5% |
| SG&A | $2.1B | $2.1B | −$19.0M | -0.9% |
| Other operating costs | $34.0M | $150M | −$116M | -77% |
| Net earnings | $751M | $693M | $58.0M | +8% |
| Minority interests | $28.0M | $26.0M | $2.0M | +8% |
| Income tax | $240M | $231M | $9.0M | +4% |
| Depreciation & amortization | $159M | $155M | $4.0M | +3% |
| Share-based compensation | $63.0M | $38.0M | $25.0M | +66% |
| Working capital & other | $198M | $109M | $89.0M | +82% |
| Operating cash flow | $1.2B | $995M | $176M | +18% |
| Free cash flow (OCF − capex) | $1.0B | $867M | $170M | +20% |
| Capital expenditures | $134M | $128M | $6.0M | +5% |
Questions
How much did Colgate Palmolive's revenue grow quarter over quarter in Q3 2026?
Colgate Palmolive's revenue rose $8.0M (+0.1%) from $5.4B in Q2 2026 to $5.4B in Q3 2026. Gross margin 60.2% against 61.5% (-1.3 pts).